Skip to main content
Caplight Logo









CytaCoat AB

CytaCoat AB

Private
SolnaHealthcare & Life Scienceshttps://www.cytacoat.com/

Last Round

VC Round

Apr 29, 2021

Total Funding Raised

$663,000

Company Overview

CytaCoat AB is a biotechnology company that develops a unique anti-fouling and anti-biofilm coating for medical devices to prevent Healthcare Associated Infections (HAIs).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

anti-biofilm coatingmedical device coatinganti-fouling coatinghydrogel coatingbiofilm preventionhealthcare-associated infectionsHAIsOEM medical devicestechnology licensingurinary catheterswound careinfection control"no-kill" coatingbiocompatible coatingsurface modificationantimicrobial resistance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CytaCoat AB Comparables

Compare CytaCoat AB with similar companies based on industry and business-model similarity.

CytaCoat AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LipoCoat
85%
BioInteractions
81%
SPARTHA Medical
78%

CytaCoat AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 29, 2021
GrantJun 1, 2019
GrantDec 1, 2017
GrantJun 1, 2015

Key People

Founding team and executive leadership

Graeme Brookes

Chief Executive Officer

Executive Team

CytaCoat AB Investors

Notable investors and investment history

CytaCoat AB investors
InvestorRounds
VinnovaGrant
Segulah Medical AccelerationVC Round
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2021

    Led by Segulah Medical Acceleration

  • Jun 1, 2019

    Secured $57K from the European Union.

CytaCoat AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CytaCoat AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CytaCoat AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersSolna
Employee Range12
Year Founded2001
Last FundingApr 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?